Find News

Filter articles

Showing 3261 to 3270 of 3367 results

Teva holds on to Azilect exclusivity


The US District Court for the District of New Jersey has found in favour of Teva Pharmaceutical Industries Ltd in its patent infringement case with Mylan over Parkinson’s disease drug Azilect.

Ranbaxy receives notice for acne drug generic


Drug company Watson Laboratories (Actavis) has notified rival Ranbaxy Laboratories that it has applied to sell a generic version of anti-acne product Absorica in the US.

Boston Scientific and OrbusNeich settle patent cases

Germany, Netherlands, Republic of Ireland, UK, US18-09-2013Legal developments

Medical device makers Boston Scientific and OrbusNeich announced on September 17 that they have settled all stent-related patent litigations.

Eli Lilly sues Canadian government for “unfair” patent rulings

Canada17-09-2013Legal developments

Eli Lilly has filed a NOA against the Canadian government, alleging recent decisions that invalidated patents covering its Zyprexa and Strattera drugs were in breach of NAFTA.

Foreign drug makers claim monopoly on Indian patents


The Indian government has awarded more than two thirds of its recent pharmaceutical patents to foreign drug makers, according to data released by the Indian Patent Office.

India recommends compulsory licence for anti-cancer drug


The Health Ministry in India has recommended that a compulsory licence is issued for the manufacture of Bristol-Myers Squibb’s anti-cancer drug Sprycel (dasatinib), potentially opening the door to the sale of cheaper imitations.

PolyTherics completes Antitope takeover


UK biopharmaceuticals company PolyTherics has completed a takeover of Antitope, a provider of antibody engineering and immunogenicity screening services.

AIPPI 2013: Pharmaceutical products and the trademark hiccup


The annual International Association for the Protection of Intellectual Property conference in Helsinki has been assessing the potential problems for pharmaceutical companies trying to brand their medicinal products.

BioEconomy Academy launches in Bangkok


Law firm Rouse has teamed up with two organisations to open the BioEconomy Academy, an initiative aimed at boosting IP use and awareness in Thailand.

Amici submit brief to support Ambry in Myriad case


The American Civil Liberties Union and other groups have submitted an amici curiae brief in support of Ambry Genetics and Gene by Gene in their patent infringement cases with Myriad Genetics Inc.

Showing 3261 to 3270 of 3367 results